Drugs News and Research

RSS

Today's OpEds: States must take on public health challenges; Placing blame for high health costs

Britain's 'reform' will do little to improve access to life-extending drugs (5/25).

25 May 2010

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

St. Jude Medical, Inc., a global medical device company, announced today at EuroPCR that the first patient was enrolled in the FAME II (Fractional Flow Reserve (FFR)-Guided Percutaneous Coronary Intervention Plus Optimal Medical Treatment vs. Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease) trial.

25 May 2010

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Alkermes, Inc. today announced that the supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence has been designated a priority review by the U.S. Food and Drug Administration (FDA).

25 May 2010

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

A new way to deliver cancer-fighting drugs using tiny particles made from lipids and chemotherapy drugs may have the power to knock out malignancies with a one-two punch. The strategy holds promise for patients with many different kinds of cancers.

25 May 2010

Significant progress on international development strategy for stem cell-derived human corneal tissue

International Stem Cell Corporation, www.intlstemcell.com, today announced significant progress on its international development strategy for stem cell-derived human corneal tissue. Such tissue can potentially be used to replace cadaver-derived corneas in treatment of severe corneal vision impairment and to eliminate the need to use live animals in safety testing of drugs, chemicals and consumer products.

25 May 2010

Clovis Oncology, Avila Therapeutics announce development agreement for NSCLC EMSI program

Clovis Oncology, Inc., a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents, and Avila Therapeutics, Inc., a biotechnology company designing targeted covalent drugs, announced today an agreement for the development and commercialization of Avila's epidermal growth factor receptor (EGFR) mutant-selective inhibitor (EMSI) program, currently in pre-clinical development for the treatment of non-small cell lung cancer (NSCLC).

25 May 2010

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

Drug discovery and development is a highly risky process, with only one in 10,000 initial candidate compounds reaching the market. When taking into account the aborted candidates, the cost of developing one successful drug may even reach $1 billion, and the development process may take as long as 15-20 years.

25 May 2010

Botvin LST Parent Program now available as e-book

The award-winning Botvin LifeSkills Training Parent Program is now available as an e-book: Princeton Health Press announced today its plan to make parent resources more accessible through the world's most popular eReader, Amazon's Kindle, as well as through the Kindle application for PCs, Mac, Blackberry and the Apple iPhone and iPad.

25 May 2010

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

Researchers at Mount Sinai School of Medicine for the first time have determined that bone marrow cells play a critical role in fighting respiratory viruses, making the bone marrow a potential therapeutic target, especially in people with compromised immune systems. They have found that during infections of the respiratory tract, cells produced by the bone marrow are instructed by proteins to migrate to the lungs to help fight infection. The data are published in the current issue of Cell Host & Microbe.

25 May 2010

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

A new animal study has found that high levels of the B-vitamin folate (folic acid) prevented heart birth defects induced by alcohol exposure in early pregnancy, a condition known as fetal alcohol syndrome.

25 May 2010

Genzyme signs consent decree of permanent injunction, agrees to disgorgement

Genzyme Corp. has signed a consent decree agreeing to correct manufacturing quality violations at its Allston, Mass., manufacturing facility and will turn over to the federal government $175 million in unlawful profits from the sale of products that were made at the plant, the U.S. Food and Drug Administration announced today.

25 May 2010

ADDF provides $248,000 grant to ALSP to allow its lead drug candidate towards clinical trials

The Alzheimer's Drug Discovery Foundation announced today that it is providing a grant of $248,000 to American Life Science Pharmaceuticals, Inc. to allow for manufacture of its lead drug candidate to be used in preclinical toxicology testing in preparation for entering Phase I clinical trials early in 2011.

25 May 2010

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

"Measles is making a rapid comeback in African, Asian and even some European countries despite being easily avoided through vaccination, the World Health Organization said Friday as countries pledged to sharply cut infections and deaths worldwide by 2015," the Associated Press reports (Jordans, 5/22). On the final day of the 63rd Annual World Health Assembly, the assembly endorsed a series of interim targets towards the global eradication of measles, VOA News reports.

25 May 2010

Experts to discuss problem of drug production and trafficking in Afghanistan

The international forum "Drug Production in Afghanistan: A Challenge for the International Community" will be held in Moscow on June 9 and 10, 2010, at Russia's initiative.

25 May 2010

Round-up: Mississippi struggles with mental health services funding cuts; A drug discount bill advances in Mass.

"Lawmakers earlier this year vigorously fought Gov. Haley Barbour's proposal to close four state mental health hospitals and six crisis centers as a budget-saving measure. Now, nonprofit-run centers that offer front-line services for the mentally ill in some of the poorest communities across Mississippi could face closure."

25 May 2010

Dermatologists recommend broad spectrum sunscreen products to protect against UVA and UVB rays

Sunscreen active ingredients, which are compounds that absorb, scatter or reflect ultraviolet (UV) light, are regulated as over-the-counter (OTC) drugs by the U.S. Food and Drug Administration (FDA).

25 May 2010

NIH, FDA launch new portal to provide easier access to online reporting

The Food and Drug Administration and the National Institutes of Health today launched a new Web site that, when fully developed, will provide a mechanism for the reporting of pre- and post-market safety data to the federal government.

25 May 2010

Media outlets highlight studies presented at International Microbicides Conference

A study in Africa, presented Sunday at the International Microbicides Conference (M2010) in Pittsburgh, has shown that a man's risk of HIV infection doubles if his HIV-positive partner is pregnant, according to HealthDay News/U.S. News & World Report.

25 May 2010

Beta-blocker medications provide new hope for patients with COPD: Study

Patients with chronic obstructive pulmonary disease may have fewer respiratory flare-ups and longer survival if they take beta-blocker medications, according to a report in the May 24 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

25 May 2010

Scientists develop DNA-vaccine that restricts supply of blood to tumours

A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.

24 May 2010

Drugs News and Research

Today's OpEds: States must take on public health challenges; Placing blame for high health costs

St. Jude Medical initiates enrollment in FAME II trial for coronary artery disease

FDA grants priority review for Alkermes' VIVITROL sNDA for opioid dependence

Nanoliposomes engineered to deliver therapeutic drugs that kill malignant cells

Significant progress on international development strategy for stem cell-derived human corneal tissue

Clovis Oncology, Avila Therapeutics announce development agreement for NSCLC EMSI program

Yissum introduces Dralgo platform to accelerate discovery of promising drug candidates

Botvin LST Parent Program now available as e-book

Researchers determine critical role of bone marrow cells in fighting respiratory viruses

Folate supplementation thwarts heart birth defects induced by alcohol exposure in early pregnancy

Genzyme signs consent decree of permanent injunction, agrees to disgorgement

ADDF provides $248,000 grant to ALSP to allow its lead drug candidate towards clinical trials

WHA endorses interim targets to eradicate measles as WHO warns disease on the rise

Experts to discuss problem of drug production and trafficking in Afghanistan

Round-up: Mississippi struggles with mental health services funding cuts; A drug discount bill advances in Mass.

Dermatologists recommend broad spectrum sunscreen products to protect against UVA and UVB rays

NIH, FDA launch new portal to provide easier access to online reporting

Media outlets highlight studies presented at International Microbicides Conference

Beta-blocker medications provide new hope for patients with COPD: Study

Scientists develop DNA-vaccine that restricts supply of blood to tumours

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News